Tandem Diabetes Care, Inc. (TNDM)
USD 17.66
(-6.51%)
USD 17.66
(-6.51%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 747.71 Million USD | -6.68% |
| 2022 | 801.21 Million USD | 14.0% |
| 2021 | 702.79 Million USD | 40.89% |
| 2020 | 498.83 Million USD | 37.68% |
| 2019 | 362.3 Million USD | 97.05% |
| 2018 | 183.86 Million USD | 70.88% |
| 2017 | 107.6 Million USD | 27.72% |
| 2016 | 84.24 Million USD | 15.65% |
| 2015 | 72.85 Million USD | 46.51% |
| 2014 | 49.72 Million USD | 71.42% |
| 2013 | 29 Million USD | 1072.13% |
| 2012 | 2.47 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 221.91 Million USD | 15.77% |
| 2024 Q1 | 191.67 Million USD | -2.6% |
| 2023 Q3 | 185.62 Million USD | -5.25% |
| 2023 Q1 | 169.38 Million USD | -23.18% |
| 2023 FY | 747.71 Million USD | -6.68% |
| 2023 Q4 | 196.79 Million USD | 6.02% |
| 2023 Q2 | 195.91 Million USD | 15.67% |
| 2022 Q2 | 200.26 Million USD | 13.85% |
| 2022 Q4 | 220.5 Million USD | 7.8% |
| 2022 FY | 801.21 Million USD | 14.0% |
| 2022 Q1 | 175.9 Million USD | -16.23% |
| 2022 Q3 | 204.54 Million USD | 2.14% |
| 2021 Q4 | 209.99 Million USD | 16.91% |
| 2021 Q3 | 179.62 Million USD | 4.35% |
| 2021 Q1 | 141.03 Million USD | -16.08% |
| 2021 Q2 | 172.13 Million USD | 22.05% |
| 2021 FY | 702.79 Million USD | 40.89% |
| 2020 Q4 | 168.06 Million USD | 35.97% |
| 2020 FY | 498.83 Million USD | 37.68% |
| 2020 Q3 | 123.6 Million USD | 13.15% |
| 2020 Q2 | 109.23 Million USD | 11.55% |
| 2020 Q1 | 97.92 Million USD | -9.66% |
| 2019 Q4 | 108.39 Million USD | 14.52% |
| 2019 FY | 362.3 Million USD | 97.05% |
| 2019 Q1 | 65.99 Million USD | -13.39% |
| 2019 Q2 | 93.25 Million USD | 41.31% |
| 2019 Q3 | 94.65 Million USD | 1.5% |
| 2018 Q3 | 46.26 Million USD | 35.57% |
| 2018 Q2 | 34.12 Million USD | 25.11% |
| 2018 Q1 | 27.27 Million USD | -32.31% |
| 2018 FY | 183.86 Million USD | 70.88% |
| 2018 Q4 | 76.19 Million USD | 64.7% |
| 2017 Q2 | 21.32 Million USD | 12.38% |
| 2017 Q1 | 18.97 Million USD | -34.36% |
| 2017 FY | 107.6 Million USD | 27.72% |
| 2017 Q4 | 40.29 Million USD | 49.22% |
| 2017 Q3 | 27 Million USD | 26.61% |
| 2016 Q1 | 20.05 Million USD | -31.12% |
| 2016 FY | 84.24 Million USD | 15.65% |
| 2016 Q2 | 22.98 Million USD | 14.59% |
| 2016 Q4 | 28.91 Million USD | 135.19% |
| 2016 Q3 | 12.29 Million USD | -46.52% |
| 2015 Q2 | 15.7 Million USD | 27.61% |
| 2015 FY | 72.85 Million USD | 46.51% |
| 2015 Q3 | 15.71 Million USD | 0.06% |
| 2015 Q1 | 12.3 Million USD | -31.2% |
| 2015 Q4 | 29.12 Million USD | 85.29% |
| 2014 Q2 | 10.25 Million USD | 27.15% |
| 2014 FY | 49.72 Million USD | 71.42% |
| 2014 Q4 | 17.88 Million USD | 32.38% |
| 2014 Q3 | 13.51 Million USD | 31.78% |
| 2014 Q1 | 8.06 Million USD | -21.27% |
| 2013 Q3 | 7.77 Million USD | 40.67% |
| 2013 Q2 | 5.52 Million USD | 1.27% |
| 2013 Q1 | 5.45 Million USD | 141.85% |
| 2013 FY | 29 Million USD | 1072.13% |
| 2013 Q4 | 10.24 Million USD | 31.74% |
| 2012 Q4 | 2.25 Million USD | 936.61% |
| 2012 Q3 | 217.72 Thousand USD | 0.0% |
| 2012 FY | 2.47 Million USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -10337.158% |
| Cerus Corporation | 156.36 Million USD | -378.181% |
| OrthoPediatrics Corp. | 148.73 Million USD | -402.728% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -77087.299% |
| Talis Biomedical Corporation | 412 Thousand USD | -181384.951% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -5317.854% |
| Inogen, Inc. | 315.66 Million USD | -136.874% |
| Spectral AI, Inc. | 18.05 Million USD | -4041.105% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -7448.894% |
| CVRx, Inc. | 39.29 Million USD | -1802.832% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -116005.28% |
| Orthofix Medical Inc. | 746.64 Million USD | -0.144% |
| Venus Concept Inc. | 76.35 Million USD | -879.278% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -6100.498% |
| Bioventus Inc. | 512.34 Million USD | -45.94% |
| BrainsWay Ltd. | 31.78 Million USD | -2252.424% |
| Envoy Medical, Inc. | 316 Thousand USD | -236519.62% |
| electroCore, Inc. | 16.03 Million USD | -4564.492% |
| IceCure Medical Ltd | 3.22 Million USD | -23056.333% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -30695.634% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -204754.808% |
| MaxCyte, Inc. | 41.28 Million USD | -1710.981% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -38196.573% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -675052.599% |
| PAVmed Inc | 2.45 Million USD | -30394.209% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -3220.387% |
| RxSight, Inc. | 89.07 Million USD | -739.406% |
| Sight Sciences, Inc. | 81.05 Million USD | -822.471% |
| SI-BONE, Inc. | 138.88 Million USD | -438.368% |
| TELA Bio, Inc. | 58.45 Million USD | -1179.178% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -3939.317% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -299.597% |
| LivaNova PLC | 1.15 Billion USD | 35.181% |
| 908 Devices Inc. | 50.22 Million USD | -1388.618% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -55.044% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -970407.762% |
| NeuroPace, Inc. | 65.42 Million USD | -1042.933% |
| LENSAR, Inc. | 42.16 Million USD | -1673.356% |
| Apyx Medical Corporation | 52.34 Million USD | -1328.333% |
| Cutera, Inc. | 212.36 Million USD | -252.084% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -2141.495% |
| BioSig Technologies, Inc. | 18 Thousand USD | -4153888.889% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -348.643% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -3021.344% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 51.496% |
| Axonics, Inc. | 366.37 Million USD | -104.083% |
| Outset Medical, Inc. | 130.37 Million USD | -473.509% |
| IRIDEX Corporation | 51.86 Million USD | -1341.551% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -449.022% |
| IRadimed Corporation | 65.56 Million USD | -1040.47% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -63481.463% |
| INVO Bioscience, Inc. | 3.02 Million USD | -24654.161% |
| Telesis Bio, Inc. | 27.5 Million USD | -2618.085% |
| Viemed Healthcare, Inc. | 183 Million USD | -308.571% |
| Varex Imaging Corporation | 811 Million USD | 7.803% |
| Quipt Home Medical Corp. | 221.74 Million USD | -237.202% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -988.778% |
| Dynatronics Corporation | 32.53 Million USD | -2198.269% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -8516.248% |
| Semler Scientific, Inc. | 68.18 Million USD | -996.618% |
| InMode Ltd. | 492.04 Million USD | -51.96% |
| Bruker Corporation | 2.96 Billion USD | 74.778% |
| Cytosorbents Corporation | 36.34 Million USD | -1957.031% |
| DexCom, Inc. | 3.62 Billion USD | 79.358% |
| Align Technology, Inc. | 3.86 Billion USD | 80.64% |
| Viveve Medical, Inc. | 6.42 Million USD | -11535.823% |
| ZimVie Inc. | 457.43 Million USD | -63.46% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -287.389% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -675052.599% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Profound Medical Corp. | 7.33 Million USD | -10099.371% |
| Insulet Corporation | 1.69 Billion USD | 55.941% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -493.06% |
| iCAD, Inc. | 17.31 Million USD | -4217.577% |
| Nuwellis, Inc. | 8.86 Million USD | -8335.447% |
| Biotricity, Inc. | 12.06 Million USD | -6098.264% |
| iRhythm Technologies, Inc. | 492.68 Million USD | -51.765% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -11950.25% |
| PAVmed Inc. | 2.45 Million USD | -30394.209% |
| BIOLASE, Inc. | 49.16 Million USD | -1420.865% |
| Beyond Air, Inc. | 1.15 Million USD | -64414.064% |
| FONAR Corporation | 102.88 Million USD | -626.758% |
| AxoGen, Inc. | 159.01 Million USD | -370.227% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -172.469% |
| Inari Medical, Inc. | 493.63 Million USD | -51.473% |
| UFP Technologies, Inc. | 400.07 Million USD | -86.896% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -4019889.247% |
| Tenon Medical, Inc. | 2.92 Million USD | -25436.817% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -10876.421% |
| AdaptHealth Corp. | 3.2 Billion USD | 76.635% |
| Sintx Technologies, Inc. | 2.62 Million USD | -28362.809% |
| NanoVibronix, Inc. | 2.28 Million USD | -32651.555% |
| Quanterix Corporation | 122.36 Million USD | -511.04% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -2963.79% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -272.888% |
| TransMedics Group, Inc. | 241.62 Million USD | -209.456% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -5297.127% |
| NeuroMetrix, Inc. | 5.9 Million USD | -12570.126% |
| Hyperfine, Inc. | 11.03 Million USD | -6677.719% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -352.748% |
| Biomerica, Inc. | 5.41 Million USD | -13708.273% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -1378.843% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -322.12% |